Skip to main content
EHO logoEHO logo

Issuer news 16942

07/31/2024 14:30 – Inside information

INA, d.d. - Management Board meeting held on 31 July 2024

Management Board meeting held on 31 July 2024

Download document

07/31/2024 14:27 – Financial report

INA, d.d. - Financial report - 2024, Second quarter, Unrevised, Consolidated

07/31/2024 14:27 – Financial report

INA, d.d. - Financial report - 2024, Second quarter, Unrevised, Consolidated

07/31/2024 14:07 – Financial report

Granolio d.d. - Financial report - 2024, Second quarter, Unrevised, Unconsolidated

07/31/2024 14:06 – Financial report

Granolio d.d. - Financial report - 2024, Second quarter, Unrevised, Unconsolidated

07/31/2024 14:06 – Financial report

Granolio d.d. - Financial report - 2024, Second quarter, Unrevised, Consolidated

07/31/2024 14:03 – Financial report

Granolio d.d. - Financial report - 2024, Second quarter, Unrevised, Consolidated

07/31/2024 13:58 – Other information

Granolio d.d. - Notification on the held Sessions of the M. B. and S. B. 31.07.2024., Unaudited financial reports for 1H 2024 published

Download document

07/31/2024 13:51 – Financial report

LIBURNIA RIVIERA HOTELI d. d. - Financial report - 2024, Second quarter, Unrevised, Unconsolidated

07/31/2024 13:50 – Financial report

LIBURNIA RIVIERA HOTELI d. d. - Financial report - 2024, Second quarter, Unrevised, Unconsolidated

07/31/2024 13:21 – Financial report

Čakovečki mlinovi,d.d. - Financial report - 2024, Second quarter, Unrevised, Consolidated

07/31/2024 13:20 – Financial report

Čakovečki mlinovi,d.d. - Financial report - 2024, Second quarter, Unrevised, Consolidated

07/31/2024 13:16 – Financial report

Čakovečki mlinovi,d.d. - Financial report - 2024, Second quarter, Unrevised, Unconsolidated

07/31/2024 13:15 – Financial report

Čakovečki mlinovi,d.d. - Financial report - 2024, Second quarter, Unrevised, Unconsolidated

07/31/2024 12:42 – Inside information

GLUCODENT d.o.o. - Glucodent Ltd. and IQVIA have signed an agreement

Glucodent Ltd. and IQVIA have signed an agreement to develop a "Data Informed Protocol Assessment" for an oral pathology product in diabetics

Download document